Bladder Cancer
Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort.
November 29, 2023
Sex Does Not Affect Survival: A Propensity Score-Matched Comparison in a Homogenous Contemporary Radical Cystectomy Cohort.
November 28, 2023
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy.
November 28, 2023
Neoadjuvant Chemoradiotherapy Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer: Analysis of Efficacy and Safety in 119 Patients.
November 27, 2023
Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies.
November 27, 2023
Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box?
November 24, 2023
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.
November 23, 2023
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
November 22, 2023
Squamous cell carcinoma of the bladder: Demographics and outcomes associated with surgery and radiotherapy.
November 22, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.
November 21, 2023
Phase II trial of Concurrent Nivolumab and Radiation therapy in Elderly or Chemotherapy ineligible Muscle Invasive Bladder Cancer.
November 21, 2023
Clinical and Molecular Features of Nested and Large Nested Urothelial Carcinoma - Expert Commentary
November 20, 2023
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
November 20, 2023